Legal Advantage Investments’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
17,335
-200
-1% -$10.8K 0.43% 46
2026
Q1
$916K Hold
17,535
0.47% 52
2025
Q4
$1.03M Hold
17,535
0.48% 50
2025
Q3
$975K Buy
17,535
+100
+0.6% +$5.36K 0.44% 56
2025
Q2
$897K Buy
17,435
+5,000
+40% +$251K 0.42% 54
2025
Q1
$729K Hold
12,435
0.39% 60
2024
Q4
$896K Sell
12,435
-800
-6% -$58.7K 0.47% 51
2024
Q3
$1.06M Hold
13,235
0.58% 50
2024
Q2
$948K Hold
13,235
0.55% 50
2024
Q1
$932K Sell
13,235
-100
-0.7% -$7.16K 0.52% 50
2023
Q4
$1.03M Buy
13,335
+2,200
+20% +$145K 0.62% 44
2023
Q3
$758K Buy
11,135
+175
+2% +$13.8K 0.54% 50
2023
Q2
$895K Hold
10,960
0.6% 46
2023
Q1
$813K Hold
10,960
0.6% 47
2022
Q4
$908K Hold
10,960
0.75% 38
2022
Q3
$778K Buy
10,960
+160
+1% +$13.8K 0.73% 40
2022
Q2
$936K Buy
10,800
+1,200
+13% +$112K 0.91% 34
2022
Q1
$1.04M Hold
9,600
0.78% 38
2021
Q4
$1.24M Hold
9,600
0.84% 40
2021
Q3
$1.16M Hold
9,600
0.78% 42
2021
Q2
$1.08M Hold
9,600
0.74% 41
2021
Q1
$917K Hold
9,600
0.69% 41
2020
Q4
$762K Buy
+9,600
New +$695K 0.59% 48

Other funds holding TECH

Legal Advantage Investments's TECH Position: Q2 2026 in Review

Legal Advantage Investments reduced its Bio-Techne (TECH) stake by 1.1% in Q2 2026, selling an estimated $10.8K and leaving 17,335 shares worth $1.22M. The position accounts for 0.43% of the portfolio, ranked #46.

Legal Advantage Investments first reported a position in TECH in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.24M in Q4 2021. 186 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Legal Advantage Investments held 17,335 shares of Bio-Techne worth $1.22M as of Q2 2026.
  • Legal Advantage Investments sold 200 Bio-Techne shares in Q2 2026, an estimated $10.8K.
  • Bio-Techne made up 0.43% of Legal Advantage Investments's portfolio in Q2 2026, its #46 holding.
  • Legal Advantage Investments first reported a position in Bio-Techne in Q4 2020 and has held it in 23 quarters since.
  • Legal Advantage Investments's Bio-Techne position peaked at $1.24M in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.